327 related articles for article (PubMed ID: 8808705)
1. Inhibition of Raf-1 signaling by a monoclonal antibody, which interferes with Raf-1 activation and with Mek substrate binding.
Kolch W; Philipp A; Mischak H; Dutil EM; Mullen TM; Feramisco JR; Meinkoth JL; Rose DW
Oncogene; 1996 Sep; 13(6):1305-14. PubMed ID: 8808705
[TBL] [Abstract][Full Text] [Related]
2. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
Chesnel F; Bonnec G; Tardivel A; Boujard D
Dev Biol; 1997 Aug; 188(1):122-33. PubMed ID: 9245517
[TBL] [Abstract][Full Text] [Related]
4. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.
O'Hagan RC; Tozer RG; Symons M; McCormick F; Hassell JA
Oncogene; 1996 Sep; 13(6):1323-33. PubMed ID: 8808707
[TBL] [Abstract][Full Text] [Related]
5. Endothelial exposure to hypoxia induces Egr-1 expression involving PKCalpha-mediated Ras/Raf-1/ERK1/2 pathway.
Lo LW; Cheng JJ; Chiu JJ; Wung BS; Liu YC; Wang DL
J Cell Physiol; 2001 Sep; 188(3):304-12. PubMed ID: 11473356
[TBL] [Abstract][Full Text] [Related]
6. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2).
Koong AC; Chen EY; Mivechi NF; Denko NC; Stambrook P; Giaccia AJ
Cancer Res; 1994 Oct; 54(20):5273-9. PubMed ID: 7923153
[TBL] [Abstract][Full Text] [Related]
7. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
Graham TE; Pfeiffer JR; Lee RJ; Kusewitt DF; Martinez AM; Foutz T; Wilson BS; Oliver JM
J Immunol; 1998 Dec; 161(12):6733-44. PubMed ID: 9862703
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism.
Arai H; Escobedo JA
Mol Pharmacol; 1996 Sep; 50(3):522-8. PubMed ID: 8794890
[TBL] [Abstract][Full Text] [Related]
9. CrkL plays a role in SDF-1-induced activation of the Raf-1/MEK/Erk pathway through Ras and Rac to mediate chemotactic signaling in hematopoietic cells.
Arai A; Aoki M; Weihua Y; Jin A; Miura O
Cell Signal; 2006 Dec; 18(12):2162-71. PubMed ID: 16781119
[TBL] [Abstract][Full Text] [Related]
10. Interactions between Ras and Raf: key regulatory proteins in cellular transformation.
Marshall M
Mol Reprod Dev; 1995 Dec; 42(4):493-9. PubMed ID: 8607981
[TBL] [Abstract][Full Text] [Related]
11. Ras stimulates DNA topoisomerase II alpha through MEK: a link between oncogenic signaling and a therapeutic target.
Chen G; Templeton D; Suttle DP; Stacey DW
Oncogene; 1999 Nov; 18(50):7149-60. PubMed ID: 10597316
[TBL] [Abstract][Full Text] [Related]
12. Integrity of c-Raf-1/MEK signal transduction cascade is essential for hepatitis B virus gene expression.
Stöckl L; Berting A; Malkowski B; Foerste R; Hofschneider PH; Hildt E
Oncogene; 2003 May; 22(17):2604-10. PubMed ID: 12730674
[TBL] [Abstract][Full Text] [Related]
13. The insulin/Ras pathway of adipocytic differentiation of 3T3 L1 cells: dissociation between Raf-1 kinase and the MAPK/RSK cascade.
Porras A; Santos E
Int J Obes Relat Metab Disord; 1996 Mar; 20 Suppl 3():S43-51. PubMed ID: 8680477
[TBL] [Abstract][Full Text] [Related]
14. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells.
Takahashi T; Ueno H; Shibuya M
Oncogene; 1999 Apr; 18(13):2221-30. PubMed ID: 10327068
[TBL] [Abstract][Full Text] [Related]
15. A dominant role for the Raf-MEK pathway in forskolin, 12-O-tetradecanoyl-phorbol acetate, and platelet-derived growth factor-induced CREB (cAMP-responsive element-binding protein) activation, uncoupled from serine 133 phosphorylation in NIH 3T3 cells.
Seternes OM; Johansen B; Moens U
Mol Endocrinol; 1999 Jul; 13(7):1071-83. PubMed ID: 10406459
[TBL] [Abstract][Full Text] [Related]
16. Thyrotropin-induced mitogenesis is Ras dependent but appears to bypass the Raf-dependent cytoplasmic kinase cascade.
al-Alawi N; Rose DW; Buckmaster C; Ahn N; Rapp U; Meinkoth J; Feramisco JR
Mol Cell Biol; 1995 Mar; 15(3):1162-8. PubMed ID: 7862110
[TBL] [Abstract][Full Text] [Related]
17. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA
Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of Raf by ceramide-activated protein kinase.
Yao B; Zhang Y; Delikat S; Mathias S; Basu S; Kolesnick R
Nature; 1995 Nov; 378(6554):307-10. PubMed ID: 7477354
[TBL] [Abstract][Full Text] [Related]
19. Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation.
Vanderkuur JA; Butch ER; Waters SB; Pessin JE; Guan KL; Carter-Su C
Endocrinology; 1997 Oct; 138(10):4301-7. PubMed ID: 9322943
[TBL] [Abstract][Full Text] [Related]
20. Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway.
Schulte TW; Blagosklonny MV; Romanova L; Mushinski JF; Monia BP; Johnston JF; Nguyen P; Trepel J; Neckers LM
Mol Cell Biol; 1996 Oct; 16(10):5839-45. PubMed ID: 8816498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
